Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Biotech IPOs in the current market environment? Experts say it's 'a bit silly, if not suicidal'
Fierce Biotech
Tue, 02/22/22 - 10:40 am
biotech
IPOs
pandemic
COVID-19
Merck’s Anti-Covid Pill Shows Better Effectiveness In Indian Study
Forbes
Sun, 02/20/22 - 11:56 am
Merck
Ridgeback Biotherapeutics
molnupiravir
antivirals
COVID-19
Tracking mental health: Lundbeck partnership debuts US mapping dashboard tool
Endpoints
Sun, 02/20/22 - 11:51 am
Lundbeck
mental health
COVID-19
FDA’s Califf shares priority list with agency staff
RAPS.org
Sun, 02/20/22 - 11:50 am
FDA
regulatory
Robert Califf
pandemic
COVID-19
misinformation
Is the clock ticking on Moderna's patent promise? Activists fear South African patents could hinder vaccine production
Endpoints
Fri, 02/18/22 - 10:39 am
Moderna Therapeutics
vaccines
COVID-19
South Africa
patents
intellectual property
FDA updates Merck's Covid-19 pill EUA and reaffirms it should only be used as a last resort
Endpoints
Fri, 02/18/22 - 10:25 am
Merck
molnupiravir
FDA
Pfizer
COVID-19
antivirals
Paxlovid
Canada Authorizes Novavax’s Non-MRNA Covid Vaccine For Use In Adults
Forbes
Thu, 02/17/22 - 11:26 pm
Canada
Novavax
vaccines
COVID-19
As Omicron fears fade, pandemic restrictions are being dismantled. And that's a big deal for some biopharmas
Endpoints
Thu, 02/17/22 - 10:54 am
COVID-19
pandemic
COVID-19 variants
vaccines
Alvea launches trials of shelf-stable DNA vaccine against new SARS-CoV-2 variants
Biopharma Reporter
Thu, 02/17/22 - 10:50 am
Alvea
vaccines
DNA
COVID-19
COVID-19 variants clinical trials
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Pfizer
AstraZeneca
vaccines
COVID-19
Roche
Covid-19 vaccine maker Moderna to set up subsidiary in Singapore as it boosts regional presence
Today Online, Singapore
Wed, 02/16/22 - 10:55 am
Moderna Therapeutics
Singapore
Asia
vaccines
COVID-19
Worried About Pfizer's Post-Pandemic Growth? These 14 Words from Pfizer's CEO Should Reassure You.
Motley Fool
Wed, 02/16/22 - 10:46 am
Pfizer
Pharma CEOs
Albert Bourla
pandemic
vaccines
COVID-19
With FDA nods and third-shot OKs, Moderna and Pfizer boost vaccine ads – and booster messages
Endpoints
Tue, 02/15/22 - 11:24 pm
Moderna Therapeutics
Pfizer
BioNTech
COVID-19
vaccines
pharma marketing
DTC advertising
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
Fierce Pharma
Mon, 02/14/22 - 10:53 am
AstraZeneca
COVID-19
Evushield
HHS
Pfizer stalls COVID-19 vaccine app as it awaits data on third dose in young kids
Fierce Pharma
Sat, 02/12/22 - 11:58 pm
Pfizer
COVID-19
vaccines
clinical trials
pediatric
Breaking Down Pfizer and Moderna's Omicron-Specific Vaccine Trials
Motley Fool
Sat, 02/12/22 - 11:54 pm
Pfizer
Moderna Therapeutics
clinical trials
vaccines
COVID-19
Omicron COVID-19 variant
Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful
Fierce Pharma
Fri, 02/11/22 - 11:48 am
Eli Lilly
monoclonal antibodies
COVID-19
bebtelovimab
Novavax says its vaccine is 80% effective in teens, but manufacturing questions continue to cloud future
Endpoints
Thu, 02/10/22 - 10:17 pm
Novavax
vaccines
clinical trials
adolescents
COVID-19
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world
Fierce Biotech
Thu, 02/10/22 - 10:46 am
AstraZeneca
COVID-19
vaccines
AZD2816
Vaxzevria
Pascal Soriot: AstraZeneca 'on track' to hit big $40B goal, capping years-long turnaround campaign
Endpoints
Thu, 02/10/22 - 10:42 am
AstraZeneca
earnings
vaccines
COVID-19
Pascal Soriot
Pharma CEOs
Pages
« first
‹ previous
…
30
31
32
33
34
35
36
37
38
…
next ›
last »